NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Screening for Infectious Diseases Among Substance Abusers

Screening for Infectious Diseases Among Substance Abusers

Treatment Improvement Protocol (TIP) Series, No. 6


Rockville (MD): Substance Abuse and Mental Health Services Administration (US); .
Report No.: (SMA) 95-3060

This TIP focuses on infectious diseases that are prevalent in and especially harmful to patients in drug treatment, and that can be medically managed by treatment staff or through referrals for primary care. The treatment recommendations in this TIP are largely, but not exclusively, based on guidelines from the Centers for Disease Control and Prevention (CDC). Trained medical staff are needed to diagnose and treat these diseases. Treatment providers who do not offer such medical resources are encouraged to refer their patients to community-based health care professionals. Followup care of those patients referred initially to other health care professionals should be provided.


This publication is part of the Substance Abuse Prevention and Treatment Block Grant technical assistance program. This publication was written under contract number ADM 270-90-0001 from the Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration (SAMHSA). Richard Bast served as the Government project officer. Stuart M Berman, MD; Bernard Branson, MD, Beth A Dillon, MSW; Samuel W Dooley, Jr, MD; Dorothy C Gunter, MPH; Christopher H Hayden; Robert Johnson, MD, MPH; T Stephen Jones, MD; Bess Miller, MD, MSc; Louis B Polish, MD; William O Schalla, MS; George Schmid, MD; and Ronald O Valdiserri, MD, MPH, of the Centers for Disease Control and Prevention, served as technical experts. Text development was provided by Mollie Sayers, Patricia Kassebaum, and Dixie McGough.

The opinions expressed herein are those of the Consensus Panel members and do not reflect the official position of SAMHSA or any other part of the U.S. Department of Health and Human Services (DHHS). No official support or endorsement of SAMHSA or DHHS is intended or should be inferred. The guidelines proffered in this document should not be considered as substitutes for individualized patient care and treatment decisions.

The U.S. Government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in this publication are used only because they are considered essential in the context of this Treatment Improvement Protocol.

Care has been taken to make the information in this Treatment Improvement Protocol current. However, the user of this document should realize that regimens for treating infectious diseases do change, especially in the treatment of HIV/AIDS and multidrug-resistant tuberculosis. If there is any question about the appropriateness of nay information contained in this protocol, or question about whether the information is current with the latest advances in treatment, the reader is encouraged to consult a specialist in infectious diseases.

Bookshelf ID: NBK64727PMID: 22514863
PubReader format: click here to try


  • PubReader
  • Print View
  • Cite this Page

Related information

Related citations in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...